Scarica l'app Stockscreener
264.84
0.06%
0.15
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$264.69
Aprire:
$263.87
Volume 24 ore:
1.45M
Relative Volume:
0.84
Capitalizzazione di mercato:
$51.53B
Reddito:
$328.68B
Utile/perdita netta:
$2.55B
Rapporto P/E:
20.32
EPS:
13.0349
Flusso di cassa netto:
$1.56B
1 W Prestazione:
-2.19%
1M Prestazione:
-12.88%
6M Prestazione:
-24.48%
1 anno Prestazione:
-9.32%
Intervallo 1D:
$263.83
$268.20
Intervallo di 1 settimana:
$262.67
$272.27
Portata 52W:
$244.82
$377.54
Cencora Inc Stock (COR) Company Profile
Nome
Cencora Inc
Settore
Industria
Telefono
610-727-7000
Indirizzo
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR vs MCK, CAH, HSIC, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
264.84 | 51.50B | 328.68B | 2.55B | 1.56B | 13.03 |
MCK
Mckesson Corp
|
736.78 | 88.33B | 403.43B | 5.10B | 5.41B | 38.47 |
CAH
Cardinal Health Inc
|
194.88 | 45.71B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
76.04 | 8.70B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
1.45 | 1.28B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-29 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2026-01-22 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-06-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | Ripresa | Mizuho | Outperform |
| 2024-09-18 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Equal Weight |
| 2023-03-31 | Iniziato | Citigroup | Buy |
| 2023-01-31 | Ripresa | Evercore ISI | Outperform |
| 2022-10-11 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-08-22 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-07-11 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-06-07 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2022-05-26 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-04-12 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2021-03-12 | Ripresa | Evercore ISI | In-line |
| 2021-02-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-02-02 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2021-01-06 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2021-01-06 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | Iniziato | Mizuho | Neutral |
| 2020-08-06 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | Iniziato | Barclays | Underweight |
| 2020-06-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | Ripresa | Credit Suisse | Outperform |
| 2020-04-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-03-17 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-02-11 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-07-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | Iniziato | Guggenheim | Buy |
| 2019-04-10 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-02-11 | Downgrade | JP Morgan | Neutral → Underweight |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-10 | Downgrade | Jefferies | Buy → Hold |
| 2018-10-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | Iniziato | Berenberg | Buy |
| 2018-07-17 | Ripresa | Stifel | Hold |
| 2018-04-09 | Iniziato | MoffettNathanson | Buy |
| 2018-03-12 | Aggiornamento | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | Iniziato | JP Morgan | Neutral |
| 2017-09-22 | Iniziato | William Blair | Outperform |
Mostra tutto
Cencora Inc Borsa (COR) Ultime notizie
Cencora (COR) Has a Specialty-Distribution Moat That Looks Stronger Than Its Thin Margins Suggest - AlphaStreet
Cencora Inc. stock (US15135B1017): new Kite CAR T-cell distribution deal highlights specialty focus - AD HOC NEWS
Cencora-Kite Agreement Signals CGT Commercialization Shift - Pharmaceutical Commerce
Cencora Inc stock (US03073E1055): shares steady ahead of next earnings after recent legal headlines - AD HOC NEWS
Billions spent, a new CFO, and a bold vision: Cencora is transforming healthcare from Conshohocken - MSN
Is Cencora’s New CFO, $2 Billion Buyback, and Lawsuit Trio Altering The Investment Case For Cencora (COR)? - Yahoo Finance
Deals tracker: Ohio hospital, OhioHealth drop merger plans - Modern Healthcare
Cencora Inc. stock outperforms competitors despite losses on the day - MarketWatch
Cencora Inc. stock (US15135B1017): shares ease while investors digest new corporate responsibility r - AD HOC NEWS
Cencora, Inc. (COR) Stock Analysis: Evaluating a 32% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Cencora Inc. stock (US15135B1017): steady trading as NYSE healthcare distributor holds fiscal 2026 E - AD HOC NEWS
Insider Spends US$1.1m Buying More Shares In Cencora - simplywall.st
Cencora Appoints Eva Boratto as CFO and Reaffirms 2026 Financial Guidance - Minichart
Cencora appoints Eva Boratto as CFO, reaffirms guidance - MSN
Cencora Inc. stock (US15135B1017): new CFO appointment and 2026 EPS guidance reaffirmed - AD HOC NEWS
Assessing Cencora (COR) Valuation After Recent Share Price Weakness And Long Term Gains - simplywall.st
Cencora, Inc. (COR) Appoints New CFO and Reaffirms Financial Gui - GuruFocus
Eva C. Boratto named Cencora Executive VP & CFO as James F. Cleary to retire - TradingView
Cencora (NYSE: COR) hires new CFO Eva Boratto and reaffirms 2026 and long-term EPS targets - Stock Titan
Insider Buying: Dermot Durcan Acquires Shares of Cencora Inc (CO - GuruFocus
Cencora director D. Mark Durcan buys $1.07m in stock By Investing.com - Investing.com Canada
Cencora director D. Mark Durcan buys $1.07m in stock - Investing.com
Cencora Insider Bought Shares Worth $1,065,040, According to a Recent SEC Filing - marketscreener.com
Director Dermot Durcan adds 4,000 Cencora (NYSE: COR) shares - Stock Titan
Cencora Inc. (COR) Holds Steady Near Support as Neutral Trading ContinuesBull Pennant - thelegaladvocate.com
Cencora Inc. stock (US15135B1017): shares react to investor investigations after guidance reaffirmat - AD HOC NEWS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc.COR - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Cencora, Inc. (COR) And Encourages Shareholders to Reach Out - ACCESS Newswire
Cencora, Inc. Announce CFO Changes - marketscreener.com
Cencora, Inc. Announces Executive Changes - marketscreener.com
Cencora Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Is Cencora (COR) Starting To Look Attractive After Recent Healthcare Distribution Headlines? - simplywall.st
Cencora (COR) Reaffirms FY26 Adjusted EPS Guidance - GuruFocus
Cencora hits 52-week low after guidance cut - MSN
CAH vs. COR: Which Healthcare Distributor Stock Is the Better Buy? - TradingView
Cencora names Eva Boratto as CFO, reaffirms fiscal 2026 guidance By Investing.com - Investing.com Australia
Cencora names Eva Boratto as CFO, reaffirms fiscal 2026 guidance - Investing.com
Cencora nabs ex-CVS exec as new CFO - Yahoo Finance
Ex-Bath & Body Works CFO tapped to guide Cencora’s 2026 earnings - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Cencora, Inc. (COR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Cencora Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Cencora, Inc. (COR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Cencora, Inc. (COR) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Cencora, Inc. (COR) Stock Analysis: Healthcare Giant With A 29.80% Upside Potential - DirectorsTalk Interviews
If You Invested $100 In Cencora Stock 10 Years Ago, You Would Have This Much Today - Sahm
Cencora Inc. stock (US15135B1017): new leadership move as former CEO returns as chair amid healthcar - AD HOC NEWS
Cencora raises earnings outlook on share repurchases - MSN
BlackRock Mid-Cap Growth Equity Portfolio's Cencora Inc(COR) Holding History - GuruFocus
Cencora Inc (COR) Stock Up 3.6% and Still Undervalued -- GF Scor - GuruFocus
Cencora (COR) Q1 2026 Earnings: EPS Misses Estimates But Stock Rises on Resilient OperationsEarnings Surprise Report - thelegaladvocate.com
Cencora Inc Azioni (COR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.14%
0.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):